Alexandria Real Estate Equities, Inc. reports news as a life science real estate investment trust that owns, operates and develops collaborative Megacampus™ ecosystems in major life science innovation clusters. Company updates commonly cover operating results, funds from operations, leasing activity, rental-rate trends and property-market demand across locations such as Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle and New York City.
Recurring announcements also include quarterly common stock dividends, balance-sheet and liquidity commentary, capital recycling activity, senior note offerings, cash tender offers for outstanding debt and corporate governance or leadership matters tied to the REIT’s public-company structure.
Moderna, Inc. (NASDAQ: MRNA) has announced plans to invest in a new 462,000 sq. ft. science center in Cambridge, Massachusetts, aiming for LEED Zero certification. This facility will support its mRNA therapeutics and vaccines, focusing on sustainability and collaboration. Construction has begun, with phased move-in expected in 2023. Alexandria Real Estate Equities (NYSE: ARE) is the development partner, while Jones Lang LaSalle (NYSE: JLL) facilitated the site selection. Moderna's pipeline includes 37 programs, 22 of which are in clinical studies.
Alexandria Real Estate Equities (NYSE: ARE) announced that OneFifteen, a non-profit healthcare ecosystem for opioid addiction recovery, received an honorable mention in Fast Company's 2021 Innovation by Design Awards. This award highlights Alexandria's role in tackling the opioid crisis, which caused over 95,000 deaths in the U.S. by February 2021. The OneFifteen campus in Dayton, Ohio, developed in partnership with Verily, features comprehensive addiction care and has helped over 3,500 patients since 2019. This recognition emphasizes Alexandria's commitment to innovative solutions in public health.
Summary not available.
On September 10, 2021, Alexandria Real Estate Equities (NYSE: ARE) announced that its executive chairman, Joel S. Marcus, received the Distinction in Civic Engagement and Renewal award from the National September 11 Memorial & Museum. This honor recognizes his contributions to the Memorial's mission, particularly in commemorating the victims of the 9/11 attacks. Alexandria will also participate in the 9/11 Tribute in Lights on September 11, lighting up its NYC campus in 'Memorial Blue'. The company maintains a strong commitment to social impact, addressing key societal issues such as health and food insecurity.
Alexandria Real Estate Equities declared a quarterly cash dividend of $1.12 per common share for Q3 2021, payable on October 15, 2021. This brings the total dividend for the year to $4.42, representing a 6 percent increase from the previous year. The funds from operations payout ratio remains low at 60 percent, indicating strong cash management and growth potential. The company continues to invest in its Class A properties, ensuring sustainable growth.
Alexandria Real Estate Equities (NYSE: ARE) will host a conference call and audio webcast on October 26, 2021, at 3:00 p.m. ET to discuss its third quarter operating and financial results. The results will be released after market close on October 25, 2021. Interested participants can join the call by dialing (833) 366-1125 in the U.S. or (412) 902-6738. A replay will be available from 5:00 p.m. ET on October 26, through November 2, 2021. Alexandria specializes in urban office REITs focused on life sciences and technology campuses.
On July 26, 2021, Alexandria Real Estate Equities (ARE) reported strong financial results for Q2 2021. Total revenues increased by 16.6% to $509.6 million, and net income attributable to common stockholders rose to $380.6 million, up from $226.6 million YoY. The company enjoyed historic leasing activity, with 1.9 million RSF leased and rental rate increases of 42.4%. A strong balance sheet was highlighted with $4.5 billion in liquidity, and tenant collections reached 99.4%. Alexandria continues its strategic growth, focusing on life sciences with significant ongoing and future development projects.
Summary not available.
On June 22, 2021, Alexandria Real Estate Equities announced that underwriters fully exercised their option to purchase an additional 1,050,000 shares of common stock at $184.00 per share. This follows a previously announced public offering of 7,000,000 shares. The company expects to utilize any future proceeds from forward sale agreements for pending acquisitions and general working capital. No initial proceeds from the forward purchasers will benefit Alexandria. The company is a leading urban office REIT focused on life sciences, agtech, and technology campuses.
Alexandria Real Estate Equities has closed its public offering of 7,000,000 shares of common stock priced at $184.00 per share. Although proceeds will not initially benefit the Company, future settlements from forward sale agreements will be used for pending acquisitions and general corporate purposes. Alexandria focuses on collaborative life science and technology campuses in key locations across the US. The Company made forward-looking statements regarding its planned use of proceeds, noting potential risks and uncertainties.